-
Important news
-
News
-
Shenzhen
-
China
-
World
-
Opinion
-
Sports
-
Kaleidoscope
-
Photos
-
Business
-
Markets
-
Business/Markets
-
World Economy
-
Speak Shenzhen
-
Leisure
-
Culture
-
Travel
-
Entertainment
-
Digital Paper
-
In-Depth
-
Weekend
-
Lifestyle
-
Diversions
-
Movies
-
Hotels and Food
-
Special Report
-
Yes Teens!
-
News Picks
-
Tech and Science
-
Glamour
-
Campus
-
Budding Writers
-
Fun
-
Futian Today
-
Advertorial
-
CHTF Special
-
Focus
-
Guide
-
Nanshan
-
Hit Bravo
-
People
-
Person of the week
-
Majors Forum
-
Shopping
-
Investment
-
Tech and Vogue
-
Junior Journalist Program
-
Currency Focus
-
Food and Drink
-
Restaurants
-
Yearend Review
-
QINGDAO TODAY
在线翻译:
szdaily -> Tech and Science -> 
FDA approves new test that can have ‘results within hours’
    2020-03-23  08:53    Shenzhen Daily

THE Food and Drug Administration (FDA) of the United States issued emergency authorization Saturday for a novel coronavirus (COVID-19) test kit made by Cepheid Inc. that can yield results in a matter of hours instead of days.

The new tool is called the “Cepheid Xpert Xpress SARS-CoV-2 test” and will be made available to the U.S. public by the end of the month. “The test we’re authorizing today will be able to provide Americans with results within hours, rather than days like the existing tests, and the company plans to roll it out by March 30,” the FDA said in a press release.

Health and Human Services (HHS) Secretary Alex Azar added: “With new tools like point-of-care diagnostics, we are moving into a new phase of testing, where tests will be much more easily accessible to Americans who need them.”

In a footage provided by Cepheid, which is based out of Sunnyvale, Calif., the doctor or clinician collects the patient’s biological sample with a swab. That sample is then mixed in a tube and transferred with an included pipette into the Cepheid cartridge, which contains testing reagents, according to the company. The cartridge is closed and placed into what is called a “GeneXpert machine,” which determines if the patient has been infected or not in as little as 45 minutes.

There are more than 23,000 automated GeneXpert systems across the globe, and almost 5,000 of them are in the U.S., Cepheid said in a statement.

“Our automated systems do not require users to have specialty training to perform testing — they are capable of running 24/7, with many systems already doing so today,” Cepheid president Warren Kocmond explained.

Cepheid expects to begin shipping out the test later next week. (SD-Agencies)

深圳报业集团版权所有, 未经授权禁止复制; Copyright 2010, All Rights Reserved.
Shenzhen Daily E-mail:szdaily@szszd.com.cn